Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2
Oncology Today with Dr Neil Love
00:00
Readiness for Clinical Adoption
Rinath cautions SERENA-6 is promising but not fully ready for prime time; more PFS2 and crossover data are needed.
Play episode from 56:22
Transcript
